These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23710466)

  • 1. Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study.
    Bermúdez V; Rojas J; Salazar J; Bello L; Añez R; Toledo A; Chacín M; Aguirre M; Villalobos M; Chávez M; Martínez MS; Torres W; Torres Y; Mejías J; Mengual E; Rojas L; Sánchez de Rosales M; Quevedo A; Cano R; Cabrera M; París R; Lubo A; Montiel M; Cano C
    J Diabetes Res; 2013; 2013():416451. PubMed ID: 23710466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela.
    Bermudez V; Olivar LC; Torres W; Navarro C; Gonzalez R; Espinoza C; Morocho A; Mindiola A; Chacin M; Arias V; Añez R; Salazar J; Riaño-Garzon M; Diaz-Camargo E; Bautista MJ; Rojas J
    F1000Res; 2018; 7():565. PubMed ID: 30705749
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
    Albers JJ; Slee A; O'Brien KD; Robinson JG; Kashyap ML; Kwiterovich PO; Xu P; Marcovina SM
    J Am Coll Cardiol; 2013 Oct; 62(17):1575-9. PubMed ID: 23973688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study.
    Chu NF; Makowski L; Chang JB; Wang DJ; Liou SH; Shieh SM
    Eur J Epidemiol; 2000 Jan; 16(1):5-12. PubMed ID: 10780336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela.
    Souki-Rincón A; Urdaneta J; Mengual E; Torres D; Cano-Peñaloza R; García-Camacho D; Bermúdez-Pírela V; Sorell L; Cano-Ponce C; Almarza J; Israili Z; Hernández-Hernandez R; Velasco M
    Am J Ther; 2008; 15(4):403-8. PubMed ID: 18645346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and High Sensitivity C-Reactive Protein among Patients with HIV in Ghana: The Study on Cardiovascular Risk Profile of HIV-Infected Patients on HAART (SCRIPT).
    Appiah LT; Sarfo FS; Nguah SB; Huffman MD; Stiles JK; Feinstein MJ
    Glob Heart; 2020 Nov; 15(1):74. PubMed ID: 33299770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) and cardiovascular risk in adult Mexicans.
    Cardoso-Saldaña G; Ize-Lema I; Kimura LY; Zamora González J; Posadas Romero C
    Rev Invest Clin; 1997; 49(2):85-92. PubMed ID: 9294956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Lipoprotein (a) Levels and Metabolic Syndrome in a Middle-aged and Elderly Chinese Cohort.
    Wu XY; Lin L; Qi HY; DU R; Hu CY; Ma LN; Peng K; Li M; Xu Y; Xu M; Chen YH; Lu JL; Bi YF; Wang WQ; Ning G
    Biomed Environ Sci; 2019 Jul; 32(7):477-485. PubMed ID: 31331432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.
    Hirschler V; Meroño T; Maccallini G; Gomez Rosso L; Aranda C; Brites F
    Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):78-83. PubMed ID: 21476960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Associations between metabolic syndrome and reduced lung function in young people].
    Kovalkova NA; Ragino YI; Travnikova NY; Denisova DV; Shcherbakova LV; Voevoda MI
    Ter Arkh; 2017; 89(10):54-61. PubMed ID: 29171471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.
    Motta M; Giugno I; Ruello P; Pistone G; Di Fazio I; Malaguarnera M
    Minerva Med; 2001 Oct; 92(5):301-5. PubMed ID: 11675573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein Lp(a) in obesity.
    Donatelli M; Verga S; Vaccaro M; Russo V; Bucalo ML; Scarpinato A
    Diabetes Res; 1992; 20(4):127-31. PubMed ID: 1345006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile.
    Lippi G; Montagnana M; Luca Salvagno G; Targher G; Cesare Guidi G
    Clin Cardiol; 2010 Feb; 33(2):E76-80. PubMed ID: 20043336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.
    Hippe DS; Phan BAP; Sun J; Isquith DA; O'Brien KD; Crouse JR; Anderson T; Huston J; Marcovina SM; Hatsukami TS; Yuan C; Zhao XQ
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):673-678. PubMed ID: 29301785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys.
    Sundvall J; Leiviskä J; Laatikainen T; Peltonen M; Salomaa V; Vanhala M; Korpi-Hyövälti E; Lauronen J; Alfthan G
    BMC Med Res Methodol; 2011 May; 11():63. PubMed ID: 21569280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levels.
    Julius U; Tselmin S; Schatz U; Fischer S; Birkenfeld AL; Bornstein SR
    Atheroscler Suppl; 2019 Dec; 40():1-7. PubMed ID: 31818437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of metabolic disorders and hyperinsulinemia in Mexico City.
    Zamora-González J; Yamamoto-Kimura L; Lerman-Garber I; Cardoso-Saldaña G; Fajardo-Gutierrez A; Posadas-Romero C
    Int J Obes Relat Metab Disord; 1996 Apr; 20(4):311-8. PubMed ID: 8680457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.